Patients with immune thrombocytopenia (ITP) who received a first-in-class investigational drug in addition to standard ...

Patients with relapsed or refractory (R/R) multiple myeloma who received a combination of teclistamab, a bispecific ...

When hospitals were randomly assigned to treat patients undergoing higher-risk non-cardiac surgery with tranexamic acid (TXA) ...

Type 1 diabetes is a disease in which the body mistakenly attacks itself as the immune system destroys the pancreas's insulin ...

Safety and efficacy data from a phase 1 multicenter study evaluating rapcabtagene autoleucel, an investigational ...

Researchers at The University of Texas MD Anderson Cancer Center have characterized the complex microenvironment in ...

More than half of psychologists experimented with artificial intelligence tools in their practices in the past year, but ...

The United States is poised to lose its measles-free status next year. If that happens, the country will enter an era in ...

A new study from City St George's, University of London has found that people's newspaper reading habits are a reliable ...

Doctors and researchers try to understand what medications a person has taken by asking patients directly or by looking at ...

Researchers from The University of Texas MD Anderson Cancer Center presented promising new data from two ongoing studies of ...

Patients who receive T-cell redirecting therapies are typically hospitalized for several days after treatment to watch for ...